1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. ARGEN X SE - ADR
Argen X SE - ADR XNAS: ARGX

Argen X SE - ADR Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized mya...

Read More
598.79 3.60 (0.60%)
25.71% Gain from 52W Low
263.7K
XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Argen X SE - ADR is on 31 Jul 2025 for the purpose of argenx SE Second Quarter Earnings Result for 2025 See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
34.2 / 100
Momentum Score
Technically Neutral
50.9 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
754
1Yr Price target upside is 26%
22 analysts

12

S

6

W

3

O

2

T

SWOT Analysis

Argen X SE - ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..